Jose Diaz-Pimentel
Neurology · Coral Springs, FLNPI 1659520724
Payments from drug & device makers
Across 120 payments — averaging $46.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Medtronic$1K
- Merck$799
- Abbott$591
- Biohaven Pharmaceuticals, Inc.$512
- Neurocrine Biosciences, Inc.$246
- plus $875 from 18 others
What the payments were for
- Travel & lodging$1,56228%
- Food & beverage$3,99072%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 46 | $1,469 |
| Medtronic(2 entities) | 15 | $1,060 |
| Merck | 8 | $799 |
| Abbott | 5 | $591 |
| Biohaven Pharmaceuticals, Inc. | 13 | $512 |
| Neurocrine Biosciences, Inc. | 2 | $246 |
| Boston Scientific | 1 | $185 |
| Adamas Pharmaceuticals, Inc. | 1 | $120 |
| UCB, Inc. | 3 | $90 |
| Biogen | 4 | $66 |
| Teva Pharmaceuticals USA, Inc. | 4 | $61 |
| Sanofi | 2 | $46 |
| AstraZeneca | 3 | $45 |
| Eisai Inc. | 2 | $43 |
| MDD US Operations, LLC | 2 | $33 |
| Mallinckrodt Hospital Products Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Tanabe Pharma America, Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Grifols USA, LLC | 1 | $17 |
| EMD Serono, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$595
- PERCEPT PC BRAINSENSE$548
- Infinity DBS Pulse Generators$420
- INGREZZA$246
- NURTEC ODT$236
- GENERAL DBS$185
- QULIPTA$125
- GOCOVRI$120
How this compares
$5,552 in reported general payments places this provider in the 55th percentile of 1,434 neurology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RytaryCarbidopa/Levodopa | 124 | $81,505 |
| Nurtec OdtRimegepant Sulfate | 21 | $24,153 |
| UbrelvyUbrogepant | 21 | $22,886 |
| QuliptaAtogepant | 14 | $16,237 |
| Aimovig AutoinjectorErenumab-Aooe | 17 | $15,368 |
| Rivastigmine | 327 | $14,975 |
| AptiomEslicarbazepine Acetate | 11 | $14,714 |
| XadagoSafinamide Mesylate | 11 | $13,230 |
| TopamaxTopiramate | 27 | $13,089 |
| Emgality SyringeGalcanezumab-Gnlm | 17 | $12,883 |
| NeuproRotigotine | 12 | $10,638 |
| Emgality PenGalcanezumab-Gnlm | 12 | $9,101 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 932 | $8,556 |
| Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone | 43 | $7,396 |
| Memantine Hcl | 1,165 | $5,448 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $1,469 | $39,12435 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $18 | $14,71411 claims |
| UCB, Inc.Neupro | $90 | $10,63812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,434 neurology providers in Florida.
Other neurology in Coral Springs
- Mark GoldsteinAtlantis$36.1M
- Derrick RobertsonTampa$27.6M
- Beth SafirsteinHallandale Beach$25.7M
- Michael PfefferMiami$24.5M
- Mark BrodyDelray Beach$20.5M
- Paayal PatelWest Palm Beach$17.3M
- Wendy BondFort Myers$14.7M
- William HoneycuttMaitland$14.1M
- Julie SchwartzbardAventura$13.6M
- Rekha GandhiWinter Park$13.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.